Biomedical Research

VACCINATION AGAINST YELLOW FEVER IN A PATIENT ON IMMUNOBIOLOGICAL WITH DIAGNOSIS OF PSORIATIC ARTHRITIS

Joint Event on 2^nd WORLD OBESITY CONGRESS & International Conference on DIABETES AND ENDOCRINOLOGY & 2^nd WORLD VACCINES AND IMMUNOLOGY CONGRESS
October 15-16 , 2018 | Tokyo , Japan

Patricia Avila Fabrini

Santhe Clinic, Brazil

Scientific Tracks Abstracts : Biomed Res

DOI: 10.4066/biomedicalresearch-C5-013

Abstract:

Patients with psoriatic arthritis and other immunomediated chronic diseases present a risk of infection greater than the normal population. The increased risk is due to the disease, as well as the drug therapy employed. Vaccination is one way to prevent infectious diseases. It is effective in reducing morbidity and mortaslity in patients with rheumatologic diseases undergoing immunobiological treatment. Vaccines made from dead viruses and bacteriasare indicated in this group of patients. However, vaccines containing bacterias or live virus such as yellow fever vaccine, are contra indicated because they have the potential to cause uncontrollable infection. We describe a case of a patient in use of immmunobiological drug who received yellow fever vaccine without medical consent, the side effects observed, potencial risks and management of this patient by Santhe’s staff.

Biography:

Patricia Avila Fabrini has an in fusional center in Belo Horizonte, Minas Gerais, Brazil. She has her expertise in immunobiological drugs and in her center of treatment, she also has a vaccination center for the safety use of these drugs that acts in the immune systems of patients.

E-mail: saudesanthe@hotmail.com

PDF HTML